Diabetes is known to be associated with infectious complications after orthopedic procedures, and a recent study indicates that obesity and diabetes are independent risk factors for postoperative surgical-site infections (SSIs).
The study, performed in a Finnish hospital specializing in joint replacement, explored the effects of obesity and diabetes on infection rates after primary hip and knee replacement procedures. This population-based series included 7181 hip and knee replacements performed for osteoarthritis between 2002 and 2008. Plasma glucose was measured repeatedly before and during the hospital stay, and hyperglycemia was defined as glucose ≥6.9 mmol/L (124 mg/dL). Patients were evaluated prospectively for the occurrence of periprosthetic joint infection during the year after surgery.
Joint infections were diagnosed after 52 procedures (0.72%). Morbid obesity (≥40 kg/m2 ) was associated with significantly more infections than was normal body weight (<25 kg/m2 ), with infection rates of 4.66% versus 0.37%, respectively. Morbid obesity remained significant in multivariate analysis (OR 6.4; 95% CI, 1.7-24.6), although intermediate levels of obesity (25-29, 30-34, and 35-59 kg/m2 ) were not significant. Hip replacements in morbidly obese patients were associated with a 30-fold elevation in infection risk, and knee replacements with an 8-fold increase.
Jämsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am. 2012;94(14):e1011-e1019.
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More
Barriers in seeking pelvic floor disorder treatment among ethnic minorities
May 8th 2024A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Read More
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More